Stephen Dale Hansen - 02 Dec 2025 Form 3 Insider Report for Legence Corp.

Signature
/s/ Bryce Seki, as attorney-in-fact
Issuer symbol
LGN on Nasdaq
Transactions as of
02 Dec 2025
Net transactions value
$0
Form type
3
Filing time
09 Dec 2025, 16:42:45 UTC

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hansen Stephen Dale Chief Operating Officer C/O LEGENCE CORP., 1601 LAS PLUMAS AVENUE, SAN JOSE /s/ Bryce Seki, as attorney-in-fact 09 Dec 2025 0002098161

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LGN Class A Common Stock 1,785 02 Dec 2025 Direct F1
holding LGN Class A Common Stock 15,179 02 Dec 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LGN Employee Stock Options 02 Dec 2025 Class A Common Stock 45,536 $28.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities were purchased through a directed share program in connection with Legence Corp.'s (the "Issuer") initial public offering.
F2 The reported securities represent an award of Restricted Stock Units, which each entitle the reporting person to receive, at vesting, one share of the Issuer's Class A common stock, par value $0.01 per share. The Restricted Stock Units vest in three substantially equal installments on each of the first, second and third anniversaries of the date of the award, subject generally to continued employment through the applicable vesting date.
F3 The options will vest in three substantially equal installments on each of the first, second and third anniversaries of the date of the award (September 11, 2025), subject generally to continued employment through the applicable vesting date. The options expire on the tenth anniversary of the date of the award.

Remarks:

Exhibit 24.1 - Power of Attorney